once monthly glp-1 agonist PDB-101: Molecule of the Month: Receptor Agonists GLP-1 Receptor Agonists | New

Before human translation, essential parameters to define: optimal dosing, infusion/administration route, frequency, biomarkers to monitor (senescent cell burden, inflammatory cytokines, organ function), long-term follow-up for adverse outcomes (especially tumour risk)

Every infusion is preceded by baseline liver function tests and complete blood count, and LFTs are repeated every 4 to 6 sessions

Mendoza et al

Each cocktail has been formulated by our medical director who has supported his formularies with evidence-based research

10.1016/j.lfs.2019.116940 121 WangP.PeskoeS.ByrdR.SmithP.BreslinR.ChowS

After that: It can be used daily depending on skin tolerance